GeneDx Holdings Corp.WGSNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank67
3Y CAGR-36.4%
5Y CAGR-19.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-36.4%/yr
Quarterly compound
5Y CAGR
-19.6%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 21.20% |
| Q3 2025 | 33.35% |
| Q2 2025 | 18.23% |
| Q1 2025 | 8.53% |
| Q4 2024 | -0.66% |
| Q3 2024 | 9.11% |
| Q2 2024 | -7.57% |
| Q1 2024 | -5.56% |
| Q4 2023 | -14.28% |
| Q3 2023 | -16.63% |
| Q2 2023 | 17.45% |
| Q1 2023 | -40.11% |
| Q4 2022 | 82.46% |
| Q3 2022 | -50.85% |
| Q2 2022 | 27.46% |
| Q1 2022 | -4.19% |
| Q4 2021 | 24.76% |
| Q3 2021 | 49.19% |
| Q2 2021 | -77.51% |
| Q1 2021 | 70.52% |
| Q4 2020 | 63.29% |
| Q3 2020 | 0.00% |